These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31125279)

  • 1. The Enigma of Low-Dose Ketamine for Treatment of Opioid-Induced Hyperalgesia in the Setting of Psychosocial Suffering and Cancer-Associated Pain.
    Willeford A; Atayee RS; Winters KD; Mesarwi P
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):248-255. PubMed ID: 31125279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful Treatment of Opioid-Refractory Cancer Pain with Short-Course, Low-Dose Ketamine.
    Waldfogel JM; Nesbit S; Cohen SP; Dy SM
    J Pain Palliat Care Pharmacother; 2016 Dec; 30(4):294-297. PubMed ID: 27754734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC; Davies D; Desai S; Malherbe S
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents.
    Finkel JC; Pestieau SR; Quezado ZM
    J Pain; 2007 Jun; 8(6):515-21. PubMed ID: 17434801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: Utility of Ketamine, Lidocaine, and Mexiletine as Nonopioid Adjuvants in Complex Cancer-Associated Pain.
    Hakim RC; Edmonds KP; Atayee RS
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):15-19. PubMed ID: 29737933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-sparing effect of intravenous outpatient ketamine infusions appears short-lived in chronic-pain patients with high opioid requirements.
    Kapural L; Kapural M; Bensitel T; Sessler DI
    Pain Physician; 2010; 13(4):389-94. PubMed ID: 20648208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Opioid-Induced Hyperalgesia.
    Wall J; Chauhan A
    J Pain Palliat Care Pharmacother; 2018; 32(2-3):158-160. PubMed ID: 30592628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.
    Amin P; Roeland E; Atayee R
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):233-42. PubMed ID: 25102039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Ketamine and Opioid Rotation in the Management of Opioid Induced Hyperalgesia in a Patient With Acute Promyelocytic Leukemia.
    Hino C; Ran-Castillo D; Akhtari M; Cao H; Silvestre J
    J Oncol Pharm Pract; 2022 Jul; 28(5):1254-1258. PubMed ID: 35068247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with ketamine in a 12-year-old girl with severe neuropathic pain caused by a cervical spinal tumor.
    Klepstad P; Borchgrevink P; Hval B; Flaat S; Kaasa S
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):616-9. PubMed ID: 11902308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parecoxib for opioid-induced hyperalgesia.
    Kellett E; Berman R; Morgan H; Collins J
    BMJ Support Palliat Care; 2021 Jun; 11(2):126-127. PubMed ID: 32601152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful reversal of hyperalgesia/myoclonus complex with low-dose ketamine infusion.
    Forero M; Chan PS; Restrepo-Garces CE
    Pain Pract; 2012 Feb; 12(2):154-8. PubMed ID: 21676160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postdelivery of alfentanil and ketamine has no effect on intradermal capsaicin-induced pain and hyperalgesia.
    Wallace MS; Braun J; Schulteis G
    Clin J Pain; 2002; 18(6):373-9. PubMed ID: 12441831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Antihyperalgesic and Opioid-Sparing Effects of 5-Day Ketamine and Morphine Infusion ("Burst Ketamine") in Diabetic Neuropathic Rats.
    Mak P; Broadbear JH; Kolosov A; Goodchild CS
    Pain Med; 2015 Sep; 16(9):1781-93. PubMed ID: 25800174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using methadone to treat opioid-induced hyperalgesia and refractory pain.
    Axelrod DJ; Reville B
    J Opioid Manag; 2007; 3(2):113-4. PubMed ID: 17520991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans.
    Koppert W; Sittl R; Scheuber K; Alsheimer M; Schmelz M; Schüttler J
    Anesthesiology; 2003 Jul; 99(1):152-9. PubMed ID: 12826855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of minimal-dose versus low-dose S-ketamine on opioid consumption, hyperalgesia, and postoperative delirium: a triple-blinded, randomized, active- and placebo-controlled clinical trial.
    Bornemann-Cimenti H; Wejbora M; Michaeli K; Edler A; Sandner-Kiesling A
    Minerva Anestesiol; 2016 Oct; 82(10):1069-1076. PubMed ID: 27327855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of ketamine on remifentanil-induced hyperalgesia: a double-blind, randomized study.
    Leal PC; Salomão R; Brunialti MK; Sakata RK
    J Clin Anesth; 2015 Jun; 27(4):331-7. PubMed ID: 25910532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal analgesia for severe cancer pain: A retrospective analysis of 60 patients.
    Kiehelä L; Hamunen K; Heiskanen T
    Scand J Pain; 2017 Jul; 16():140-145. PubMed ID: 28850391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.